Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...

The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility ...

Healthcare company MSD Ireland has acquired the state-of -the art WuXoi manufacturing plant in Dundalk, with the official handover expecting to take place during the first half of 2025. It was ...

The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China The MSD site in Dundalk, Co Louth. The Dundalk site will ...

Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...

Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company ...

China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD Ireland in a €500m deal. The acquisition is expected to be completed in the first half of this year and will ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...

MSD and WuXi Biologics – which have been collaborating at Dundalk since 2019 – will now begin an official handover process that aims to be completed in the first half of 2025. Meanwhile ...

MSD says it will add 150 jobs to the Dundalk plant over the coming year. The plant has been working exclusively with MSD on a 20-year vaccine supply contract since it was formally opened.

Ireland’s Foreign Direct Investment Agency (IDA) and Merck’s MSD Ireland unit revealed the ... Ireland, but the Dundalk facility will be the only one that can produce live virus vaccines.